HEMOGENYX PHARMACEUTICALS PLC: cash_and_equivalents

Value{"amount": 2532758.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2022-12-31)
Statuscurrent
EntityHEMOGENYX PHARMACEUTICALS PLC
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:2138008L93GYU5GN6179:2024-12-31
Retrieved: 2026-08-23T23:04:53.355718+02:00
Raw response sha256: 0c5d6c4a8d9962ade23d91dee1fbeea6…
Cite as: FACTANKER, https://factanker.com/fact/eace184a-7166-4e04-a543-187da9b955de

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies